Previse, a health research company developed by Baltimore-based Johns Hopkins University, has launched its first laboratory-developed test, Esopredict, for the detection of esophageal cancer.
Johns Hopkins spinoff launches GI cancer detection test
Previse, a health research company developed by Baltimore-based Johns Hopkins University, has launched its first laboratory-developed test, Esopredict, for the detection of esophageal cancer.